Thursday, October 15, 2020 12:39:24 PM
Relief (company) is a bit in the background and leaves a lot to NeuroRx and Dr. Javitt, but that is because they want to conquer the important US market (FDA) first. Once you have done that, it will be much easier to get national approvals worldwide.
Just because we practically always read about Dr. Javitt (and his NeuroRx) doesn't mean that relief doesn't play a role here. On the contrary. Relief has hired a CFO (NeuroRx not yet) and also a Chief Medical Officer.
It is clear from the PR that Relief (alone) will (or should) take care of the rest of the world. But they have limited resources at the moment and will certainly not tackle this until full FDA approval is received. It is so much easier after that...
But in my opinion the most sensible thing would be a merger between NeuroRx and Relief. (Would be much easier for GEM as well).
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM